Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal probiotic added to metronidazole for bacterial vaginosis
IRCT20180612040071N2Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Clinical symptoms of bacterial vaginosis, Vaginal pH and 1 more. Started Nov 2019; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on IRCT20180612040071N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180612040071N2.